Week In Review: Shanghai HighTide Therapeutics Files For Hong Kong IPO

HighTide Therapeutics filed for an IPO on the Hong Kong Exchange. Additionally, Shanghai Fosun Pharma will partner with the International Finance Corp to build a pharmaceutical production facility and distribution hub in the Ivory Coast for Africa.